Bottom line
How much do GGHCX and RYHIX overlap?
52% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 45.5% of GGHCX's assets and 20.6% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and RYHIX have in common
| Holding | % of GGHCX | % of RYHIX | Overlap |
|---|---|---|---|
| Eli Lilly and Co. | 10.59% | 3.63% | 3.63% |
| Johnson & Johnson | 6.76% | 2.88% | 2.88% |
| UnitedHealth Group Inc. | 6.17% | 2.22% | 2.22% |
| Merck & Co., Inc. | 4.59% | 2.04% | 2.04% |
| AbbVie Inc. | 4.03% | 2.52% | 2.52% |
| Gilead Sciences, Inc. | 3.63% | 1.39% | 1.39% |
| CVS Health Corp. | 2.52% | 1.31% | 1.31% |
| Cardinal Health, Inc. | 2.10% | 0.86% | 0.86% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.34% | 1.34% |
| Edwards Lifesciences Corp. | 1.56% | 0.84% | 0.84% |
| Thermo Fisher Scientific Inc. | 1.55% | 1.61% | 1.55% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Only in RYHIX
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Intuitive Surgical Inc — 1.31%
- Danaher Corp — 1.30%
- Pfizer Inc — 1.25%
- Bristol-myers Squibb Company — 1.22%
- Stryker Corp — 1.21%
- Mckesson Corp — 1.05%
- Elevance Health Inc — 1.02%
- Cigna Group (the) — 0.94%
- Regeneron Pharmaceuticals Inc — 0.90%
- Hca Healthcare Inc — 0.87%
- Boston Scientific Corp — 0.86%
- Novo Nordisk A/s — 0.83%
Asset mix
| Asset type | GGHCX | RYHIX |
|---|---|---|
| Stocks | 97.5% | 83.2% |
| Cash & short-term funds | 8.8% | — |
| Repurchase agreements | — | 0.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | GGHCX | RYHIX |
|---|---|---|
| US | 93.5% | 73.0% |
| NL | 3.4% | 0.7% |
| IE | 0.6% | 3.3% |
| GB | 3.1% | 1.8% |
| CH | 2.7% | 2.3% |
| DK | 1.1% | 1.4% |
| BE | 1.2% | — |
| IL | 0.4% | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do GGHCX and RYHIX overlap?
What stocks do GGHCX and RYHIX have in common?
Should I own both GGHCX and RYHIX?
Which holds more stocks, GGHCX or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.